The UK-French Trade Commission UBIFRANCE assists French companies with their development in the British market for an extensive range of sectors. IPI speaks with Katie Docwra of UBIFRANCE about the future in Franco-British trade relations.
2011 has been an interesting year for those using the ICH eCTD standard. Several agencies or groups of agencies have made changes related to their use of eCTD. The US FDA released new validation rules late in 2010 and now plans to implement them later this year. Health Canada has announced that it intends to release a new version of its Module 1 this year. In this article Charles Mathis of the LORENZ Life Sciences Group focuses on changes which have already been implemented by the European Agencies, with the implementation of new validation criteria.
In the life science industries the requirement for intellectual property rights to protect innovation is taken as a given. It is also taken as a given that those working in these industries know what intellectual property rights are and what they mean to the business. However, this is a complicated area and assumptions made may be turn out to be misguided. In this article Vicki Salmon of IP Asset LLP aims to provide an introduction to some relevant intellectual property rights and to give an indication as to how these can be strategically used for the benefit of different types of life science businesses.